Combating cancer versatility involves a multifaceted approach. Researchers are focusing on targeted therapies that attack specific genetic mutations and pathways. Additionally, the development of novel drugs that can disrupt the tumor microenvironment and the use of advanced technologies like CRISPR for gene editing hold promise for more effective treatments.
